KFDA - NewsChannel 10 / Amarillo, TX: newschannel10.comOsiris gets $15M milestone payment from NuVasive
Member Center:
 |
 |
NEW YORK (AP) - Osiris Therapeutics Inc. said Tuesday it received a $15 million payment from NuVasive Inc., the final milestone fee linked to the sale of Osiris' bone graft stem cell business.
San Diego-based NuVasive agreed to buy the Osteocel business in May 2008 for as much as $85 million. Thelatest payment was triggered when NuVasive reached $35 million in total Osteocel revenue.
Shares of Osiris, which is headquartered in Columbia, Md., fell 33 cents, or 5.5 percent, to close at $5.72 on Tuesday, having hit a 52-week low of $5.35 earlier in the session. NuVasive stock rose 65 cents to finish at $35.70.
Copyright 2009 The Associated Press. All rights reserved. This material may not be published, broadcast, rewritten or redistributed.
Click here to find daily tax tips, forms, rules, and FAQ's. Brought to you by Jackson-Hewitt.
